Identifying components for programmatic latent tuberculosis infection control in the European Union

Autor: Marieke J. van der Werf, Sake J. de Vlas, Jannigje M Vonk Noordegraaf-Schouten, Andreas Sandgren, Gerarda B van Kessel, Anouk M. Oordt-Speets
Přispěvatelé: Public Health
Rok vydání: 2016
Předmět:
medicine.medical_specialty
Tuberculosis
Epidemiology
infectious disease
latent tuberculosis infection
Population
Antitubercular Agents
03 medical and health sciences
0302 clinical medicine
Risk groups
SDG 3 - Good Health and Well-being
Latent Tuberculosis
Risk Factors
Environmental protection
Surveys and Questionnaires
Virology
Active tb
Health care
Humans
Infection control
Medicine
media_common.cataloged_instance
European Union
030212 general & internal medicine
Program Development
European union
education
media_common
education.field_of_study
Latent tuberculosis
Tuberculin Test
business.industry
public health
Public Health
Environmental and Occupational Health

health policy
Mycobacterium tuberculosis
bacterial infections and mycoses
medicine.disease
Prevention and control
030228 respiratory system
Family medicine
Perspective
Practice Guidelines as Topic
business
Zdroj: Eurosurveillance, 21(34):30325, 20-24. European Centre for Disease Prevention and Control (ECDC)
Eurosurveillance
ISSN: 1560-7917
DOI: 10.2807/1560-7917.es.2016.21.34.30325
Popis: Individuals with latent tuberculosis infection (LTBI) are the reservoir of Mycobacterium tuberculosis in a population and as long as this reservoir exists, elimination of tuberculosis (TB) will not be feasible. In 2013, the European Centre for Disease Prevention and Control (ECDC) started an assessment of benefits and risks of introducing programmatic LTBI control, with the aim of providing guidance on how to incorporate LTBI control into national TB strategies in European Union/European Economic Area (EU/EEA) Member States and candidate countries. In a first step, experts from the Member States, candidate countries, and international and national organisations were consulted on the components of programmatic LTBI control that should be considered and evaluated in literature reviews, mathematical models and cost-effectiveness studies. This was done through a questionnaire and two interactive discussion rounds. The main components identified were identification and targeting of risk groups, determinants of LTBI and progression to active TB, optimal diagnostic tests for LTBI, effective preventive treatment regimens, and to explore the potential for combining LTBI control with other health programmes. Political commitment, a solid healthcare infrastructure, and favourable economic situation in specific countries were identified as essential to facilitate the implementation of programmatic LTBI control.
Databáze: OpenAIRE